Policy / Pricing US launches probe of German ‘underpayment’ for medicines PharmaphorumA Section 301 probe by the US Trade Representative into Germany's medicine pricing and reimbursement policies raises the threat of punitive tariffs.Read full story pharminent June 19, 2026 (Last updated: June 22, 2026) Pharmaphorum A Section 301 probe by the US Trade Representative into Germany’s medicine pricing and reimbursement policies raises the threat of punitive tariffs. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Biogen to acquire RayThera for up to $1bnNext: Denali sells FDA voucher for $195M to support neurodegenerative pipeline Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
